Stockholders' Equity - Schedule of Warrant Activity (Details) - Warrants [Member] - USD ($) |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Schedule of Warrant Activity [Line Items] | ||
| Number of Warrants, Outstanding and exercisable beginning balance | 125,000 | |
| Weighted Average Exercise Price, Outstanding and exercisable beginning balance | $ 4.8 | |
| Weighted Average Remaining Contractual Term (Years), Outstanding and exercisable | 1 year 7 months 2 days | |
| Aggregate Intrinsic Value, Outstanding and exercisable, beginning balance | ||
| Number of Warrants, Granted | ||
| Number of Warrants, Expired | ||
| Number of Warrants, Exercised | ||
| Aggregate Intrinsic Value, Granted (in Dollars) | ||
| Number of Warrants, Outstanding and exercisable ending balance | 125,000 | 125,000 |
| Weighted Average Exercise Price, Outstanding and exercisable ending balance | $ 4.8 | $ 4.8 |
| Aggregate Intrinsic Value, Outstanding and exercisable, ending balance |
| X | ||||||||||
- Definition Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Exercised No definition available.
|
| X | ||||||||||
- Definition Aggregate Intrinsic Value, Granted. No definition available.
|
| X | ||||||||||
- Definition Aggregate Intrinsic Value, Outstanding and exercisable ending balance. No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for equity-based award excluding option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|